Avstera Therapeutics Corp. — Form D
Avstera Therapeutics Corp. of MALVERN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-03. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-03
- Form: D
- Accession: 0001878281-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 1
- Date of first sale: 2023-09-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-493670
Issuer
- Name: Avstera Therapeutics Corp.
- CIK: 0001878281
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 365 PHOENIXVILLE PIKE, MALVERN, PA, 19355
- Phone: 2679250454
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Ajay Raju | Director | PHILADELPHIA, PA |
| Karthik Musunuri | Executive Officer | Chester Springs, PA |
Other filings by this issuer (2)
More